NCT05462613
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05462613
Title Regorafenib With Low-dose Chemotherapies and Aspirin Followed by Standard Chemotherapies in Metastatic Colorectal Cancer (REPROGRAM-02)
Acronym REPROGRAM-02
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Centre Hospitalier Universitaire de Besancon
Indications
Therapies
Age Groups: adult | senior
Covered Countries FRA

Facility Status City State Zip Country Details
CHU de Besançon Besançon France Details
CHU Estain Clermont-Ferrand France Details
Hôpital Henri Mondor Créteil France Details
Centre Georges François Leclerc Dijon France Details
Hôpital Privé Jean Mermoz Lyon France Details
Hôpital Nord Franche Comté Montbéliard France Details
CHU Montpellier Montpellier France Details
Groupe hospitalier de la région de Mulhouse et Sud Alsace Mulhouse France Details
Centre Antoine Lacassagne Nice France Details
Hôpital Européen Georges Pompidou Paris France Details
Hôpital la Pitié-Salpétrière Paris France Details
Hôpital Saint antoine Paris France Details
Institut Mutualiste Montsouris Paris France Details
CHU de Reims - Hôpital Robert Debré Reims France Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field